Member Info for crumbs

Ray Lindy will be I want that money now!
It has been the stumbling block that has constantly held her up.... however she also knows the market value potential of her techs too.... We can all hope first there is success in trials (of course) second we all go along for the ride together and get to share in rewards equally...

Maybe the diggles shouldnt have been selling already then :p

So the reading of that is... all the directors 'except' Diggle ...

'consider that the terms of the related party transaction are fair and reasonable insofar as Shareholders are concerned.'

'The independent Directors for the purpose of the Capital Raise, (being all of the Directors except Martin Diggle who is a co-founder and portfolio manager of Vulpes and a non-executive Director), having consulted with the Company's nominated adviser, Panmure Gordon, consider that the terms of the related party transaction are fair and reasonable insofar as Shareholders are concerned.'

I do hope Vulpes stay.... that they could be willing to push for more of their own control would not be a bad thing (hope there is no bad feelings withing the BOD,if possible)...
The best outcome.... great data coming in on all trials... BIG money pharma deals we have seen those on early data -$1 billion upfronts...a NASDAQ listing and vulpes redmile and anyone else can then leave as they please :) all happening by 2 years time....only possible with this funding though.

It seems though we can now maybe say it was not Vulpes and their due diligence that brought in redmile as now it looks like they are nudging the fox out of the way... so.... BioNTech? it is the only relationship connection that looks clear.

An impasse C7... this needs resolving.

Thought about it and voted yes... I believe Evans was planning on voting yes (from his last posting about this) too even though he expressed concerns and that there were others with concerns... well we are all concerned at one holder gaining full power but I'm more concerned at never seeing a moditope in a trial!.... Diggle or any other big no voters has not come out to talk to us so... if he would like to.... we are here!

Vulpes buying 100 million on the open market lol .... go for it I say!

Trebor I used their online chat to an operative and did it in seconds...

Ahh, so those already voted need do nothing but can if they choose change their minds.... not likely though?

Yes is it not that they want to get as close to 100% of votes in as possible not a complete re-vote?
As stated in RNS there are some shareholders who have indicated they need a little longer but intend to vote yes... not sure how scancell came to know that lol or why they needed more time... sounds a bit made up to me

It's ok my vote is in now (thanks barbel, was easy) so it is a done deal and if C7 throws his in too well.... even redmile does not have that kind of holding! :p

It's ok my vote is in now (thanks barbel, was easy) so it is a done deal and if C7 throws his in too well.... even redmile does not have that kind of holding! :p

Why I'm voting Yes...
'The Board believes that a strengthened balance sheet affords the ability to extract maximum value from this expanded development pipeline by advancing several lead programmes to the clinic in parallel. '

But they then must deliver!

We have this to go off:

'Cliff Holloway, CEO of Scancell said "The additional funds from the proposed New Convertible Loan Notes would allow Scancell to accelerate its development pipeline by advancing multiple programmes from its different platform technologies in parallel. Importantly, this would mitigate risk versus our current, more sequential approach to asset development. Further, the additional capital would provide the Company with greater flexibility for any corporate development and partnering activities it may wish to undertake and thereby maximise the potential to increase shareholder value. I encourage those shareholders who have not yet voted to consider the merits to the Company of the additional funding from the New Convertible Loan Notes and to make use of the extended voting deadline for the adjourned General Meeting."

'Following completion of the Subscription, the Company currently has an unaudited cash balance of approximately £25 million. However, the Board believes that the proceeds of the New Convertible Loan Notes, if received, would significantly further strengthen its balance sheet and provide additional flexibility to further extend the utility of the Company's ImmunoBody®, Moditope® and AvidiMab™/TaG antibody products and platforms to accelerate and broaden its development pipeline of new potential novel therapies. The Board believes that a strengthened balance sheet affords the ability to extract maximum value from this expanded development pipeline by advancing several lead programmes to the clinic in parallel. To achieve this the Company needs to expand its development and clinical operations capabilities to meet time critical milestones. Further, as outlined in the Capital Raise Announcement and the Circular, the additional capital from the issue of the New Convertible Loan Notes will provide the Company with greater flexibility regarding the execution of its development plans to ensure both optimal development and commercialisation strategies can be pursued and to limit the potential impact on the Company of economic pressures caused by COVID-19.'

I agree would have been better to have been more informed on any issues relating to getting it passed

Then it should have put more in! We need progress and for that funds... bugger the better
However not an ideal situ to have the 2 biggest investors at odds... unless it is a minor thing... if it is not will there be a BOD shuffle and a redmile incomer? ...

Ok thanks barbel

Is the ref number from the corporate action ?

Ivy all very last minute that is for sure.. especially if it is Vulpes